0

537536

DENISCHEM

img img img img
No Data Available

DENIS CHEM LAB LTD Share Price Update

As of the latest trading session, DENIS CHEM LAB LTD is trading at ₹70.9, up by ₹0.59 or 0.83% from its previous close. The stock has moved between ₹69.00 and ₹71.00 today. Over the past year, the stock has delivered a return of -30.31%. In the last month, it has returned -9.79%.

Investment Returns

Over 1 Month -9.79% Over 3 Months -7.67% Over 6 Months -17.16% Over 1 Year -30.31%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DENIS CHEM LAB LTD fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 98.40
  • P/E Ratio (TTM) 11.29
  • Beta 0.76
  • Book Value / share 63.23
  • Return on equity 9.77%
  • EPS (TTM) 6.28
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 3.32
info icon alternate text

DENIS CHEM LAB LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 45.52
Operating Expense 41.55
Net Profit 3.32
Net Profit Margin (%) 7.29
Earnings Per Share (EPS) 2.39
EBITDA 6.46
Effective Tax Rate (%) 24.71
Particulars SEP 2025 (Values in Cr)
Revenue 46.17
Operating Expense 43.79
Net Profit 2.21
Net Profit Margin (%) 4.78
Earnings Per Share (EPS) 1.60
EBITDA 4.91
Effective Tax Rate (%) 26.73
Particulars JUN 2025 (Values in Cr)
Revenue 43.28
Operating Expense 40.26
Net Profit 2.48
Net Profit Margin (%) 5.73
Earnings Per Share (EPS) 1.78
EBITDA 7.09
Effective Tax Rate (%) 25.30
Particulars MAR 2025 (Values in Cr)
Revenue 41.38
Operating Expense 41.29
Net Profit 0.71
Net Profit Margin (%) 1.71
Earnings Per Share (EPS) 0.51
EBITDA 3.23
Effective Tax Rate (%) 44.09
Particulars DEC 2024 (Values in Cr)
Revenue 42.84
Operating Expense 40.93
Net Profit 1.76
Net Profit Margin (%) 4.10
Earnings Per Share (EPS) 1.27
EBITDA 4.13
Effective Tax Rate (%) 20.72
Particulars MAR 2025 (Values in Cr)
Revenue 173.30
Operating Expense 164.56
Net Profit 8.08
Net Profit Margin (%) 4.66
Earnings Per Share (EPS) 5.82
EBITDA 18.48
Effective Tax Rate (%) 27.36
Particulars MAR 2024 (Values in Cr)
Revenue 167.82
Operating Expense 154.07
Net Profit 11.16
Net Profit Margin (%) 6.64
Earnings Per Share (EPS) 8.04
EBITDA 22.62
Effective Tax Rate (%) 26.30
Particulars MAR 2023 (Values in Cr)
Revenue 160.85
Operating Expense 150.51
Net Profit 7.86
Net Profit Margin (%) 4.88
Earnings Per Share (EPS) 5.66
EBITDA 19.38
Effective Tax Rate (%) 28.02
Particulars MAR 2022 (Values in Cr)
Revenue 136.56
Operating Expense 128.72
Net Profit 6.26
Net Profit Margin (%) 4.58
Earnings Per Share (EPS) 4.51
EBITDA 15.40
Effective Tax Rate (%) 29.50
Particulars MAR 2021 (Values in Cr)
Revenue 109.32
Operating Expense 106.57
Net Profit 2.26
Net Profit Margin (%) 2.06
Earnings Per Share (EPS) 1.63
EBITDA 10.60
Effective Tax Rate (%) 26.53
Particulars MAR 2025 (Values in Cr)
Book Value / Share 61.33
ROE % 9.77
ROCE % 13.83
Total Debt to Total Equity 0.01
EBITDA Margin 10.66
Particulars MAR 2024 (Values in Cr)
Book Value / Share 57.91
ROE % 14.62
ROCE % 20.07
Total Debt to Total Equity 0.02
EBITDA Margin 13.48
Particulars MAR 2023 (Values in Cr)
Book Value / Share 52.08
ROE % 11.33
ROCE % 15.98
Total Debt to Total Equity 0.04
EBITDA Margin 12.04
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.89
ROE % 9.78
ROCE % 13.60
Total Debt to Total Equity 0.09
EBITDA Margin 11.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 44.32
ROE % 3.75
ROCE % 6.36
Total Debt to Total Equity 0.18
EBITDA Margin 9.70
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 26.23
Total Assets 112.27
Total Liabilities 112.27
Total Equity 85.10
Share Outstanding 1
Price to Book Ratio 1.51
Return on Assets (%) 7.19
Return on Capital (%) 9.4
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.14
Total Assets 109.34
Total Liabilities 109.34
Total Equity 80.36
Share Outstanding 1
Price to Book Ratio 2.60
Return on Assets (%) 10.20
Return on Capital (%) 13.7
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 16.93
Total Assets 99.44
Total Liabilities 99.44
Total Equity 72.26
Share Outstanding 1
Price to Book Ratio 1.22
Return on Assets (%) 7.90
Return on Capital (%) 10.59
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.82
Total Assets 96.38
Total Liabilities 96.38
Total Equity 66.45
Share Outstanding 1
Price to Book Ratio 1.42
Return on Assets (%) 6.49
Return on Capital (%) 8.99
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.54
Total Assets 92.26
Total Liabilities 92.26
Total Equity 61.50
Share Outstanding 1
Price to Book Ratio 0.84
Return on Assets (%) 2.45
Return on Capital (%) 3.23
Particulars MAR 2025 (Values in Cr)
Net Income 11.11
Cash from Operations 16.97
Cash from Investing -8.22
Cash from Financing -4.20
Net change in Cash -0.34
Free Cash Flow 16.97
Particulars MAR 2024 (Values in Cr)
Net Income 15.13
Cash from Operations 22.15
Cash from Investing -14.89
Cash from Financing -4.20
Net change in Cash -1.28
Free Cash Flow 22.15
Particulars MAR 2023 (Values in Cr)
Net Income 10.91
Cash from Operations 18.73
Cash from Investing -11.15
Cash from Financing -4.00
Net change in Cash 1.17
Free Cash Flow 18.73
Particulars MAR 2022 (Values in Cr)
Net Income 8.88
Cash from Operations 18.15
Cash from Investing -10.13
Cash from Financing -7.20
Net change in Cash -0.26
Free Cash Flow 18.15
Particulars MAR 2021 (Values in Cr)
Net Income 3.08
Cash from Operations 8.68
Cash from Investing -1.12
Cash from Financing -5.50
Net change in Cash 1.33
Free Cash Flow 8.68
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.07 13.67 1.60 253.43 23.12 40.00
BLISS GVS PHARMA LTD. 300.20 24.29 2.66 3175.78 118.35 304.30
CIPLA LTD. 1398.95 27.70 3.28 113007.26 1165.55 1672.20
FERMENTA BIOTECH LIMITED 302.65 10.07 2.27 890.73 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2309.80 38.33 17.25 39129.41 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.07 23.13 4.26 253.43 23.12 40.00
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8604.25 103.40 26.92 21510.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 300.20 32.28 2.74 3175.78 118.35 304.30

DENIS CHEM LAB LTD shareholding pattern

Holding
61.01%
38.98%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

DENIS CHEM LAB LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
70.90 0.83 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 71.20
  • 26 Days 74.30
  • 10 Days 72.50
  • 50 Days 74.80
  • 12 Days 72.90
  • 100 Days 77.00
  • 20 Days 73.90
  • 200 Days 85.20
71.07 PIVOT
First Support 69.23 First Resistance 72.14 Second Support 68.16 Second Resistance 73.98 Third Support 66.32 Third Resistance 75.05
RSI 40.92 ADX 19.19 MACD -1.37 Williams % R -79.84 Commodity Channel Index (CCI) -126.23
Date 2026-05-22 Week 6832.00 Same Day 8007.00 Month 7512.00
1 Year 0.76 3 Year 0.98
Over 1 Month
-9.79% down
Over 1 Year
-30.31% down
Over 3 Months
-7.67% down
Over 3 Years
-3.19% down
Over 6 Months
-17.16% down
Over 5 Years
3.81% down

DENIS CHEM LAB LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2025 1.5 Final 19 Sep 2025 Equity shares
19 Sep 2024 2.5 Final 20 Sep 2024 Equity shares
22 Sep 2023 2.0 Final 23 Sep 2023 Equity shares
20 Sep 2022 1.5 Final 22 Sep 2022 Equity shares
20 Sep 2021 0.75 Final 22 Sep 2021 Equity shares
18 Sep 2019 1.0 Final 20 Sep 2019 Equity shares

Top Gainers

Top Losers

DENIS CHEM LAB LTD Share Price

Denis Chem Lab Limited was incorporated in 1980 and was converted into a Public Limited Company in 1982. The Company was registered with Directorate General of Technical Development (DGTD) for manufacturing 4 million bottles of I.V. Fluids and 75 MT of Bulk Drugs per annum and started commercial production for sterile Intravenous (IV) Injectibles in 1984 and also came up with a rights issue during the year In 1995, it ventured into manufacturing of IV Fluids in PP bottles using BFS technology.

The Company is engaged in manufacturing of Pharmaceuticals Transfusion Solution in Bottles. The Company products are manufactured in ultra modern plant using automatic equipments and facilities, which are conforming to GMP specifications as per WHO norms.

These products are filled in glass bottles in volume of 100 ml, 250 ml, 500 ml and 1000 ml. in aseptic condition and followed by terminal sterilization. The Company introduced I.V. Fluids facility in plastic bottles using Blow Fill Seal (BFS) technology, which commissioned in 2007-08. It started manufacturing of I.V. Fluids in P.P. Plastic bottles using latest BFS technology with an installed capacity of 15 million units per annum in 2016.

In 2018-19, the Company implemented a project with the addition of 100 ml Eurohead products to its Aquapulse' Brand and made it operational on November 1, 2018.

During FY 2023, Company commissioned the expansion in 100 ML Eurohead 'Aquapulse', in June 2021, adding a capacity of 12,00,000 bottles per month.

Parent organization Indian Private
NSE symbol [-]
Founded 1980
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Denis Chem Lab Ltd?

Answer Field

Denis Chem Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 70.90 as on May 22 2026 03:23 PM.

What is the Market Cap of Denis Chem Lab Ltd Share?

Answer Field

The market cap of Denis Chem Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 98.40 as on May 22 2026 03:23 PM.

What is the 52 Week High and Low of Denis Chem Lab Ltd?

Answer Field

The 52 Week High and Low of Denis Chem Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 114.85 and ₹ 56.10.

What is 1 year return for Denis Chem Lab Ltd?

Answer Field

The 1 year returns on the stock has been -30.31%.

What is the P/E Ratio of Denis Chem Lab Ltd Share?

Answer Field

As on May 22 2026 03:23 PM the price-to-earnings (PE) ratio for Denis Chem Lab Ltd share is 11.29.

What is the PB ratio of Denis Chem Lab Ltd Share?

Answer Field

As on May 22 2026 03:23 PM, the price-to-book (PB) ratio for Denis Chem Lab Ltd share is 63.23.

How to Buy Denis Chem Lab Ltd Share?

Answer Field

You can trade in Denis Chem Lab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Denis Chem Lab Ltd Share on Bajaj Broking App?

Answer Field

To buy Denis Chem Lab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Denis Chem Lab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|